Benzinga - Feed Your Mind.

Market Overview

News

Saturday, April 13, 2013

KYTHERA Biopharmaceuticals Presents Positive MRI Results from Phase IIb Study of ATX-101 in Reduction of Double Chin (Earnings, KYTH, News, Guidance, Contracts, Asset Sales, M&A, Global / Sat, 09:18pm)

Saturday, April 06, 2013

KYTHERA Biopharmaceuticals Announces Positive Interim Phase IIIb Results from Open-Label Study of ATX-101 (KYTH, News, Guidance, Asset Sales, Management / Sat, 10:52am)

Saturday, March 02, 2013

KYTHERA Announces Positive Interim Results from Open-Label Study of ATX-101 in Reduction of 'Double Chin' (KYTH, News, Guidance, Financing, Contracts, Management / Sat, 11:46am)

Wednesday, November 28, 2012

KYTHERA Reports Results from Open-Label Study for ATX-101 (KYTH, News, FDA / Wed, 09:12am)
KYTHERA Biopharma Says Pleased with Study Results on ATX-101 (KYTH, News, FDA / Wed, 09:07am)

Tuesday, October 16, 2012

KYTHERA Biopharma Closes IPO of 5.1M Shares at $16 per Share (KYTH, News, Offerings, IPOs / Tue, 10:49am)

Benzinga Professional

Brain Trust

Shopping Around

MORE FROM Michael Prus

Stocks to Watch for the Week of May 20, 2013

InvestorsObserver

MORE FROM InvestorsObserver

The Next Chapter…

MORE FROM Matt Newman

See All Brain Trust Columnists

stats for benzinga